홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Triethylamine → Cbz-aminoglutarimide

HRID 1009083
인쇄

반응식

HRID 1009083 반응식
N1[CH:6]=[CH:5][C:4]2[C:7]([O:9][C:10](=[O:11])[C:3]=2[CH:2]=1)=O.[NH2:12][CH:13]1[CH2:19][CH2:18][C:17](=[O:20])[NH:16][C:14]1=[O:15].[CH2:21](N(CC)CC)C>>[C:10]([C:13]1([NH2:12])[CH2:19][CH2:18][C:17](=[O:20])[NH:16][C:14]1=[O:15])([O:9][CH2:7][C:4]1[CH:5]=[CH:6][CH:21]=[CH:2][CH:3]=1)=[O:11]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 8471TriethylamineHCID 1345083-Amino-2,6-piperidinedioneHCID 2783981H,3H-furo(3,4-c)pyridine-1,3-dione

생성물 1

HCID 67017964Cbz-aminoglutarimide수율 17%

실험 절차

With reference to Scheme 4 below, azathalidomide was prepared from aminoglutarimide and commercial pyridine-3,4-dicarboxylic anhydride. Cbz-aminoglutarimide was deprotected by hydrogenolysis with catalyst palladium hydroxide on carbon (10%) to form aminoglutarimide. Pyridine-3,4-dicarboxyic anhydride was refluxed with aminoglutarimide in the presence of triethylamine to yield azathalidomide 11 in the total yield of 17% from Cbz-aminoglutarimide.

출처 및 근거

ORD 기록
ord-f516af7b368c44cfb603e9e95043cd8b
출처 데이터셋
uspto-grants-2011_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07973057B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트